HICON

Jubilant DraxImage Inc., dba Jubilant Radiopharma🇺🇸 United States

FDA Page

Effective Date: May 17, 2022
Approval ID: 524a0dac-6e2b-2c0c-04b4-76d85dba63c5
Products: 1 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use HICON safely and effectively. See full prescribing information for HICON.HICON (for the preparation of sodium iodide I 131 solution or sodium iodide I 131 capsules), therapeutic, for oral use.Initial U.S. Approval: 1971

Quick Stats

Total Products1

Labelers2

Label Sections15

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.